Interleukin-1 receptor-associated kinase: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(18 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='2a9i' size='340' side='right' caption='Mouse IRAK4 death domain complex with Mn+2 ion , [[2a9i]]' scene=''> | |||
== Function == | |||
'''Interleukin-1 receptor-associated kinase''' (IRAK) is a kinase involved in signaling innate immune responses from Toll-like receptors and interleukin-1 receptor-related proteins<ref>PMID:8599092</ref>. | |||
*'''Interleukin-1 receptor-associated kinase 1''' (IRAK1) is a key link in the chain of events initiated by the binding of ligands to IL-R and Toll-like receptor <ref>PMID:30279971</ref>. | |||
*'''Interleukin-1 receptor-associated kinase 2''' (IRAK2) is involved in ER stress-induced cell death<ref>PMID:23724040</ref>. | |||
*'''Interleukin-1 receptor-associated kinase 3''' (IRAK3) is a critical modulator of inflammation in innate immunity<ref>PMID:33382782</ref>. | |||
*'''Interleukin-1 receptor-associated kinase 4''' (IRAK4) has scaffold function in myddosome formation <ref>PMID:30076215</ref>. | |||
== Relevance == | |||
IRAK4 is involved in early recognition of pathogens and the initiation of inflammation when fighting infection. | |||
==3D structures of | == Disease == | ||
IRAK4 deficiency is a disorder which causes recurrent bacterial infections. | |||
</StructureSection> | |||
==3D structures of interleukin-1 receptor-associated kinase== | |||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | |||
{{#tree:id=OrganizedByTopic|openlevels=0| | |||
*IRAK1 | |||
**[[6bfn]] – hIRAK1 residues 194-530 - human<br /> | |||
[[2nru]], [[2nry]], [[2oib]], [[2o8y]] – hIRAK4 kinase domain | *IRAK2 | ||
[[ | |||
[[ | **[[3mop]] – hIRAK2 DEATH domain + hIRAK4 DEATH domain + MYD88 <br /> | ||
[[ | |||
[[2oid]] - hIRAK4 kinase domain + AMPPNP<br /> | *IRAK3; Domains – DEATH 4-106; pseudokinase 145-454 | ||
[[3mop]] - hIRAK4 DEATH domain + hIRAK2 DEATH domain + MYD88 | |||
**[[5uke]] – hIRAK3 DEATH domain (mutant) - NMR<br /> | |||
**[[6ziw]] – hIRAK3 pseudokinase domain + ATPgS <br /> | |||
**[[6ruu]] – hIRAK3 pseudokinase domain <br /> | |||
*IRAK4 kinase domain residues 30-336; DEATH domain residues 4-106 | |||
**[[2nru]], [[2nry]], [[2oib]], [[2o8y]], [[4rmz]] – hIRAK4 kinase domain <br /> | |||
**[[4u97]], [[4u9a]] - hIRAK4 kinase domain (mutant)<br /> | |||
**[[2oic]], [[4xs2]] - hIRAK4 kinase domain + staurosporine<br /> | |||
**[[4y73]], [[4yo6]], [[4yp8]], [[4ztl]], [[4ztm]], [[4ztn]], [[5kx7]], [[5kx8]], [[5t1s]], [[5t1t]], [[5uiq]], [[5uir]], [[5uis]], [[5uit]], [[5uiu]], [[6f3d]], [[6f3e]], [[6f3g]], [[6f3i]], [[6lxy]], [[6n8g]], [[6o8u]], [[6o94]], [[6o95]], [[6o9d]], [[6thw]], [[6thx]], [[6thz]], [[6ti8]], [[6tia]], [[6uya]], [[6vql]], [[7c2v]], [[7c2w]], [[7og1]], [[7qg2]], [[7qg3]], [[7qg5]], [[8dks]] - hIRAK4 kinase domain + inhibitor<br />, | |||
**[[5w84]], [[5w85]], [[5k72]], [[5k75]], [[5k76]], [[5k7g]], [[5k7i]], [[6ega]], [[6eg9]], [[6egd]], [[6ege]], [[6egf]], [[6mom]], [[6rfi]], [[6rfj]] - hIRAK4 residues 154-460 + inhibitor<br /> | |||
**[[2oid]] - hIRAK4 kinase domain + AMPPNP<br /> | |||
**[[3mop]] - hIRAK4 DEATH domain + hIRAK2 DEATH domain + MYD88<br /> | |||
**[[1wh4]] – mIRAK4 DEATH domain – mouse – NMR<br /> | |||
**[[2a9i]] - mIRAK4 DEATH domain<br /> | |||
}} | |||
== References == | |||
<references/> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |